• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

更新:2018 年 5 月 20 日至 10 月 13 日美国和全球的流感活动。

Update: Influenza Activity - United States and Worldwide, May 20-October 13, 2018.

出版信息

MMWR Morb Mortal Wkly Rep. 2018 Oct 26;67(42):1178-1185. doi: 10.15585/mmwr.mm6742a3.

DOI:10.15585/mmwr.mm6742a3
PMID:30359347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6290813/
Abstract

During May 20-October 13, 2018,* low levels of influenza activity were reported in the United States, with a mix of influenza A and B viruses circulating. Seasonal influenza activity in the Southern Hemisphere was low overall, with influenza A(H1N1)pdm09 predominating in many regions. Antigenic testing of available influenza A and B viruses indicated that no significant antigenic drift in circulating viruses had emerged. In late September, the components for the 2019 Southern Hemisphere influenza vaccine were selected and included an incremental update to the A(H3N2) vaccine virus used in egg-based vaccine manufacturing; no change was recommended for the A(H3N2) component of cell-manufactured or recombinant influenza vaccines. Annual influenza vaccination is the best method for preventing influenza illness and its complications, and all persons aged ≥6 months who do not have contraindications should receive influenza vaccine, preferably before the onset of influenza circulation in their community, which often begins in October and peaks during December-February. Health care providers should offer vaccination by the end of October and should continue to recommend and administer influenza vaccine to previously unvaccinated patients throughout the 2018-19 influenza season (1). In addition, during May 20-October 13, a small number of nonhuman influenza "variant" virus infections were reported in the United States; most were associated with exposure to swine. Although limited human-to-human transmission might have occurred in one instance, no ongoing community transmission was identified. Vulnerable populations, especially young children and other persons at high risk for serious influenza complications, should avoid swine barns at agricultural fairs, or close contact with swine..

摘要

2018 年 5 月 20 日至 10 月 13 日期间,*美国报告流感活动水平较低,同时存在甲型和乙型流感病毒共同传播的情况。南半球的季节性流感活动总体较低,许多地区以甲型流感病毒(H1N1)pdm09 为主。对现有甲型和乙型流感病毒的抗原性检测表明,流行病毒未出现明显抗原漂移。9 月下旬,选定了 2019 年南半球流感疫苗的组份,包括对基于鸡蛋的疫苗生产中使用的 A(H3N2)疫苗病毒进行了增量更新;细胞生产或重组流感疫苗的 A(H3N2)组份无需更改。每年接种流感疫苗是预防流感疾病及其并发症的最佳方法,所有无禁忌证的≥6 月龄人群均应接种流感疫苗,最好在其所在社区流感流行开始之前接种,通常在 10 月开始,12 月至 2 月达到高峰。卫生保健提供者应在 10 月底之前提供疫苗接种,并应在整个 2018-19 流感季节继续向以前未接种疫苗的患者推荐和接种流感疫苗(1)。此外,在 2018 年 5 月 20 日至 10 月 13 日期间,美国报告了少数非人类流感“变异”病毒感染;大多数与接触猪有关。尽管在一个病例中可能发生了有限的人际传播,但未发现持续的社区传播。脆弱人群,尤其是幼儿和其他有发生严重流感并发症风险的人,应避免在农业展览会上进入猪圈,或避免与猪近距离接触。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8208/6290813/e7c87867dbed/mm6742a3-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8208/6290813/d70e5c762b21/mm6742a3-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8208/6290813/0db9ea650f3d/mm6742a3-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8208/6290813/e7c87867dbed/mm6742a3-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8208/6290813/d70e5c762b21/mm6742a3-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8208/6290813/0db9ea650f3d/mm6742a3-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8208/6290813/e7c87867dbed/mm6742a3-F3.jpg

相似文献

1
Update: Influenza Activity - United States and Worldwide, May 20-October 13, 2018.更新:2018 年 5 月 20 日至 10 月 13 日美国和全球的流感活动。
MMWR Morb Mortal Wkly Rep. 2018 Oct 26;67(42):1178-1185. doi: 10.15585/mmwr.mm6742a3.
2
Update: Influenza Activity - United States and Worldwide, May 19-September 28, 2019, and Composition of the 2020 Southern Hemisphere Influenza Vaccine.更新:2019 年 5 月 19 日至 9 月 28 日美国和全球的流感活动情况,以及 2020 年南半球流感疫苗的组成。
MMWR Morb Mortal Wkly Rep. 2019 Oct 11;68(40):880-884. doi: 10.15585/mmwr.mm6840a3.
3
Update: Influenza Activity - United States, October 1-November 25, 2017.更新:美国2017年10月1日至11月25日流感活动情况
MMWR Morb Mortal Wkly Rep. 2017 Dec 8;66(48):1318-1326. doi: 10.15585/mmwr.mm6648a2.
4
Update: Influenza Activity in the United States During the 2016-17 Season and Composition of the 2017-18 Influenza Vaccine.更新:2016 - 17年度美国流感疫情及2017 - 18年度流感疫苗成分
MMWR Morb Mortal Wkly Rep. 2017 Jun 30;66(25):668-676. doi: 10.15585/mmwr.mm6625a3.
5
Update: Influenza Activity - United States, October 2-December 17, 2016.更新:流感活动情况-美国,2016 年 10 月 2 日至 12 月 17 日。
MMWR Morb Mortal Wkly Rep. 2016 Dec 30;65(50-51):1439-1444. doi: 10.15585/mmwr.mm655051a5.
6
Update: Influenza Activity - United States, September 30, 2018-February 2, 2019.更新:流感活动情况-美国,2018 年 9 月 30 日-2019 年 2 月 2 日。
MMWR Morb Mortal Wkly Rep. 2019 Feb 15;68(6):125-134. doi: 10.15585/mmwr.mm6806a1.
7
Update: Influenza Activity - United States, October 2, 2016-February 4, 2017.更新:美国流感疫情——2016年10月2日至2017年2月4日
MMWR Morb Mortal Wkly Rep. 2017 Feb 17;66(6):159-166. doi: 10.15585/mmwr.mm6606a2.
8
Influenza Activity - United States, 2015-16 Season and Composition of the 2016-17 Influenza Vaccine.流感活动 - 美国,2015-16 季节和 2016-17 流感疫苗成分。
MMWR Morb Mortal Wkly Rep. 2016 Jun 10;65(22):567-75. doi: 10.15585/mmwr.mm6522a3.
9
Update: Influenza Activity--United States and Worldwide, May 24-September 5, 2015.更新:流感活动——美国和全球,2015 年 5 月 24 日-9 月 5 日。
MMWR Morb Mortal Wkly Rep. 2015 Sep 18;64(36):1011-6. doi: 10.15585/mmwr.mm6436a4.
10
Update: Influenza Activity--United States, October 4, 2015-February 6, 2016.更新:流感活动——美国,2015 年 10 月 4 日-2016 年 2 月 6 日。
MMWR Morb Mortal Wkly Rep. 2016 Feb 19;65(6):146-53. doi: 10.15585/mmwr.mm6506a3.

引用本文的文献

1
A Randomized Trial of Behavioral Nudges Delivered Through Text Messages to Increase Influenza Vaccination Among Patients With an Upcoming Primary Care Visit.通过短信提供行为提示的随机试验,以增加即将进行初级保健就诊的患者的流感疫苗接种率。
Am J Health Promot. 2023 Mar;37(3):324-332. doi: 10.1177/08901171221131021. Epub 2022 Oct 4.
2
Text Message Reminders for the Second Dose of Influenza Vaccine for Children: An RCT.短信提醒儿童接种流感疫苗第二剂:一项 RCT 研究。
Pediatrics. 2022 Sep 1;150(3). doi: 10.1542/peds.2022-056967.
3
Month of Influenza Virus Vaccination Influences Antibody Responses in Children and Adults.

本文引用的文献

1
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza Season.疫苗预防和控制季节性流感:免疫实践咨询委员会的建议-美国,2018-19 流感季节。
MMWR Recomm Rep. 2018 Aug 24;67(3):1-20. doi: 10.15585/mmwr.rr6703a1.
2
Influenza Vaccine Effectiveness Against Pediatric Deaths: 2010-2014.2010 - 2014年流感疫苗对儿童死亡的有效性
Pediatrics. 2017 May;139(5). doi: 10.1542/peds.2016-4244. Epub 2017 Apr 3.
3
Oseltamivir effect on antibiotic-treated lower respiratory tract complications in virologically positive randomized trial participants.
流感病毒疫苗接种月份影响儿童和成人的抗体反应。
Vaccines (Basel). 2021 Jan 20;9(2):68. doi: 10.3390/vaccines9020068.
4
Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret Model.基于嵌合血凝素的减毒活疫苗在临床前雪貂模型中对甲型流感病毒提供持久的保护性免疫。
Vaccines (Basel). 2021 Jan 11;9(1):40. doi: 10.3390/vaccines9010040.
5
Detection and discrimination of influenza B Victoria lineage deletion variant viruses by real-time RT-PCR.实时 RT-PCR 检测和鉴别乙型流感 B 维多利亚系缺失变异病毒。
Euro Surveill. 2020 Oct;25(41). doi: 10.2807/1560-7917.ES.2020.25.41.1900652.
6
A Heterogeneous Swine Show Circuit Drives Zoonotic Transmission of Influenza A Viruses in the United States.美国异种猪展览活动促进了流感病毒的人畜共患病传播。
J Virol. 2020 Nov 23;94(24). doi: 10.1128/JVI.01453-20.
7
Vaccination in the Elderly and IBD.老年人与炎症性肠病的疫苗接种
Curr Treat Options Gastroenterol. 2019 Dec;17(4):492-505. doi: 10.1007/s11938-019-00257-y.
8
Novel reassortant of H1N1 swine influenza virus detected in pig population in Russia.在俄罗斯的猪群中检测到新型 H1N1 猪流感病毒重组株。
Emerg Microbes Infect. 2019;8(1):1456-1464. doi: 10.1080/22221751.2019.1673136.
9
Decreasing influenza vaccine coverage among adults with high-risk chronic diseases in Spain from 2014 to 2017.西班牙 2014 至 2017 年高风险慢性病成人的流感疫苗接种率下降
Hum Vaccin Immunother. 2020;16(1):95-99. doi: 10.1080/21645515.2019.1646577. Epub 2019 Oct 22.
在病毒学检测呈阳性的随机试验参与者中,奥司他韦对抗生素治疗的下呼吸道并发症的影响。
Clin Infect Dis. 2013 Nov;57(9):1368-9. doi: 10.1093/cid/cit481. Epub 2013 Jul 24.
4
Oseltamivir and risk of lower respiratory tract complications in patients with flu symptoms: a meta-analysis of eleven randomized clinical trials.奥司他韦治疗流感样症状患者的下呼吸道并发症风险:十一项随机临床试验的荟萃分析。
Clin Infect Dis. 2011 Aug 1;53(3):277-9. doi: 10.1093/cid/cir400. Epub 2011 Jun 15.
5
Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP).抗流感病毒药物的治疗和化学预防 --- 免疫实践咨询委员会(ACIP)的建议。
MMWR Recomm Rep. 2011 Jan 21;60(1):1-24.
6
Early oseltamivir treatment of influenza in children 1-3 years of age: a randomized controlled trial.1-3 岁儿童流感的早期奥司他韦治疗:一项随机对照试验。
Clin Infect Dis. 2010 Oct 15;51(8):887-94. doi: 10.1086/656408.
7
Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children.在未接种过疫苗的5至8岁儿童中,单剂量与两剂量三价灭活流感疫苗的免疫原性和反应原性。
J Infect Dis. 2006 Oct 15;194(8):1032-9. doi: 10.1086/507309. Epub 2006 Sep 11.
8
Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.奥司他韦治疗急性流感的疗效与安全性:一项随机对照试验。神经氨酸酶抑制剂流感治疗研究组。
Lancet. 2000 May 27;355(9218):1845-50. doi: 10.1016/s0140-6736(00)02288-1.
9
Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial.扎那米韦治疗5至12岁儿童甲型和乙型流感病毒感染的症状:一项随机对照试验。
Pediatr Infect Dis J. 2000 May;19(5):410-7. doi: 10.1097/00006454-200005000-00005.
10
Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group.口服神经氨酸酶抑制剂奥司他韦治疗急性流感的疗效与安全性:一项随机对照试验。美国口服神经氨酸酶研究组。
JAMA. 2000 Feb 23;283(8):1016-24. doi: 10.1001/jama.283.8.1016.